Systemic arterial properties in pulmonary hypertension

Código QR

Systemic arterial properties in pulmonary hypertension

Guardado en:

Detalles Bibliográficos
Autores principales:	Randi Goodman, Julio A. Chirinos, Bonnie Ky, Jeremy A. Mazurek, Kerri Akaya Smith, Harold I. Palevsky, Jason S. Fritz, Steven C. Pugliese, Steven M. Kawut, Nadine Al-Naamani
Formato:	article
Lenguaje:	EN
Publicado:	SAGE Publishing 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701 Diseases of the respiratory system RC705-779
Acceso en línea:	https://doaj.org/article/1b7032c3430f4ed1aad4bedb2d45000b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Pregnancy and Pulmonary Arterial Hypertension: A Case Report
por: Ana Dias, et al.
Publicado: (2021)

The definition of pulmonary hypertension: history, practical implications and current controversies
por: Gabor Kovacs, et al.
Publicado: (2021)

Liver abnormalities in pulmonary arterial hypertension
por: Nils P. Nickel, et al.
Publicado: (2021)

Metabolic endophenotype associated with right ventricular glucose uptake in pulmonary hypertension
por: Samar Farha, et al.
Publicado: (2021)

Global trends in chronic thromboembolic pulmonary hypertension clinical trials and dissemination of results
por: Micheal C. McInnis, et al.
Publicado: (2021)

Effect of spironolactone use in pulmonary arterial hypertension – analysis from pivotal trial databases
por: Zeenat Safdar, et al.
Publicado: (2021)

Murine models of sickle cell disease and beta-thalassemia demonstrate pulmonary hypertension with distinctive features
por: Paul W. Buehler, et al.
Publicado: (2021)

“It is the fear of exercise that stops me” – attitudes and dimensions influencing physical activity in pulmonary hypertension patients
por: Ciara McCormack, et al.
Publicado: (2021)

A computational model of contributors to pulmonary hypertensive disease: impacts of whole lung and focal disease distributions
por: Behdad Shaarbaf Ebrahimi, et al.
Publicado: (2021)

PeakPCO combined with FEV1/FVC predicts vasodilator-responsive patients with idiopathic pulmonary arterial hypertension
por: Ci-Jun Luo, et al.
Publicado: (2021)

TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension
por: Robert P. Frantz, et al.
Publicado: (2021)

Blood Eosinophils and Pulmonary Rehabilitation in COPD
por: Jafar Aljazeeri, et al.
Publicado: (2021)

Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double-blind placebo-controlled study
por: Dunbar Ivy, et al.
Publicado: (2021)

Periodontal Diseases: Major Exacerbators of Pulmonary Diseases?
por: Bakey Kouanda, et al.
Publicado: (2021)

Pulmonary Hypertension in Heart Failure Patients
por: Sriram D Rao, et al.
Publicado: (2020)

Pathophysiology of pulmonary function anomalies in COVID-19 survivors
por: Pierantonio Laveneziana, et al.
Publicado: (2021)

Pulmonary vein stenosis mimicking interstitial lung disease
por: F. Carriço, et al.
Publicado: (2021)

A Conservative Approach to a Large Mycotic Pulmonary Pseudoaneurysm
por: Erin Torpey, et al.
Publicado: (2021)

Pulmonary function testing in COPD: looking beyond the curtain of FEV1
por: Sotirios Kakavas, et al.
Publicado: (2021)

Corrigendum to: Pulmonary Hypertension in Heart Failure Patients
por: Sriram D Rao, et al.
Publicado: (2020)

Underestimation of respiratory symptoms by smokers: a thorn in chronic obstructive pulmonary disease diagnosis
por: Evdoxia Gogou, et al.
Publicado: (2021)

Physical activity and risk of comorbidities in patients with chronic obstructive pulmonary disease: a cohort study
por: Tsung Yu, et al.
Publicado: (2017)

One-session bilateral sequential whole lung lavage (OSBSWLL) for the management of pulmonary alveolar proteinosis
por: Javier Diaz-Mendoza, et al.
Publicado: (2021)

Chronic obstructive pulmonary disease as a risk factor in primary care: a Canadian retrospective cohort study
por: Andrew Cave, et al.
Publicado: (2021)

Association between chronic obstructive pulmonary disease and ventricular arrhythmia: a nationwide population-based cohort study
por: Chun-Chao Chen, et al.
Publicado: (2021)

Stage 1 development of a patient-reported experience measure (PREM) for chronic obstructive pulmonary disease (COPD)
por: Susan Walker, et al.
Publicado: (2017)

Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]
por: Han MK
Publicado: (2021)

Phenotype and management of chronic obstructive pulmonary disease patients in general population in China: a nationally cross-sectional study
por: Heling Bao, et al.
Publicado: (2021)

Identifying individuals with physician-diagnosed chronic obstructive pulmonary disease in primary care electronic medical records: a retrospective chart abstraction study
por: Theresa M. Lee, et al.
Publicado: (2017)

Self-management behaviour and support among primary care COPD patients: cross-sectional analysis of data from the Birmingham Chronic Obstructive Pulmonary Disease Cohort
por: Ainee Khan, et al.
Publicado: (2017)

The clinical characteristics of patients with pulmonary hypertension combined with obstructive sleep apnoea
por: Lu Yan, et al.
Publicado: (2021)

Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension
por: Panagiota Xanthouli, et al.
Publicado: (2021)

Vascular remodeling of the small pulmonary arteries and measures of vascular pruning on computed tomography
por: Andrew J. Synn, et al.
Publicado: (2021)

Immune infiltration landscape and immune-marker molecular typing of pulmonary fibrosis with pulmonary hypertension
por: Haomin Cai, et al.
Publicado: (2021)

Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats
por: Toshikazu Ito, et al.
Publicado: (2021)

Relationship between body composition, exercise capacity and health-related quality of life in idiopathic pulmonary fibrosis
por: Martijn A Spruit, et al.
Publicado: (2021)

Clinical and physiological characteristics of, medically treated, chronic thromboembolic pulmonary hypertension patients in Saudi Arabia: A single center experience
por: Sadia Imtiaz, et al.
Publicado: (2021)

Fast decliner phenotype of chronic obstructive pulmonary disease (COPD): applying machine learning for predicting lung function loss
por: David B Price, et al.
Publicado: (2021)

Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy
por: Massimo Girardis, et al.
Publicado: (2021)

Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts
por: Maria Molina-Molina, et al.
Publicado: (2021)